Menopause and cardiovascular risk [PDF]
Menopause is not a disease, but a physiologic phase of a woman's life, due to the changes of their hormonal status. Fastidious symptoms may be associated with changes in the metabolism together with new cardiovascular risk factors, particularly aggressive for the female cardiovascular system, unprepared because of the protection due to the fertile ...
ROSSI, Rosario +5 more
openaire +3 more sources
Hypoglycemia and Cardiovascular Risks
Although hypoglycemia is the most common side effect of insulin therapy in diabetes and its morbidity is well known, for many years, the potentially life-threatening effects of hypoglycemia on the cardiovascular (CV) system have either been overlooked or have been dismissed as inconsequential to people with insulin-treated type 2 diabetes.
Frier, B.M. +2 more
openaire +3 more sources
NSAIDs and cardiovascular risk [PDF]
To the Editor: In the recent article by Wei et al.,1 it was concluded that nonsteroidal anti-inflammatory drug (NSAID) prescribing decreased after the introduction of estimated glomerular filtration rate (eGFR) reporting in April 2006 within primary care.
Bell, Samira, Marwick, Charis A
openaire +3 more sources
Sex differences in risk factors for cardiovascular disease: the PERU MIGRANT study. [PDF]
INTRODUCTION: Although men and women have similar risk factors for cardiovascular disease, many social behaviors in developing countries differ by sex. Rural-to-urban migrants have different cardiovascular risk profiles than rural or urban dwellers.
Bernabe-Ortiz Antonio +19 more
core +1 more source
Residual cardiovascular risk [PDF]
Residual cardiovascular risk is often associated with lipid abnormalities, such as atherogenic dyslipidaemia (AD). Dyslipidaemias are one of the determinants of the risk of developing atherosclerotic cardiovascular disease. In addition to low-density lipoprotein (LDL) particles, which are the most atherogenic lipoproteins, other apolipoprotein B ...
FERRARI, Roberto, Catapano, Alberico L.
openaire +2 more sources
The efficiency of cardiovascular risk assessment: do the right patients get statin treatment? [PDF]
OBJECTIVE: To evaluate targeting of statin prescribing for primary prevention to those with high cardiovascular disease (CVD) risk. DESIGN: Two cohort studies including the general population and initiators of statins aged 35-74 years.
Van Staa, Tjeerd; id_orcid +5 more
core +1 more source
Risk of death and cardiovascular outcomes with thiazolidinediones: a study with the general practice research database and secondary care data. [PDF]
To describe the likely extent of confounding in evaluating the risks of cardiovascular (CV) events and mortality in patients using diabetes medication. The General Practice Research Database was used to identify inception cohorts of insulin and different
Van Staa, Tjeerd; id_orcid +19 more
core +1 more source
Asian Cohort Studies on Cardiovascular Risk Factors in Childhood [PDF]
Long-term cohort studies have shown that cardiovascular risk factors measured during childhood were associated with levels of adult cardiovascular risk factors and also with the lifetime risk of cardiovascular disease (CVD).
김현창, 정선재, 서일
core +1 more source
ABSTRACT Background Pediatric sarcomas are a heterogeneous group of tumors that contribute disproportionately to cancer mortality in children. Although congenital anomalies are among the strongest known risk factors for childhood cancer, the risk of specific sarcoma subtypes among affected individuals has not yet been thoroughly evaluated. Procedure We
Russ Wolters +17 more
wiley +1 more source
Screening families of patients with premature coronary heart disease to identify avoidable cardiovascular risk: a cross-sectional study of family members and a general population comparison group [PDF]
<b>Background:</b> Primary prevention should be targeted at individuals with high global cardiovascular risk, but research is lacking on how best to identify such individuals in the general population.
Pell, A.C.H. +14 more
core +1 more source

